BrightSpring Health Services(BTSG)
搜索文档
BrightSpring Health Services(BTSG) - 2025 Q3 - Earnings Call Transcript
2025-10-29 05:32
BrightSpring Health Services (NasdaqGS:BTSG) Q3 2025 Earnings Call October 28, 2025 04:30 PM ET Company ParticipantsA.J. Rice - Managing DirectorKieran Ryan - Equity Research AssociateJen Phipps - CFODavid Deuchler - Managing DirectorCharles Rhyee - Managing DirectorJon Rousseau - CEOLarry Solow - PartnerConference Call ParticipantsDavid Larsen - Analyst and Managing DirectorAnn Hynes - Senior Healthcare Services Equity Analyst and Managing DirectorBrian Tanquilut - Senior Analyst, Healthcare Services, and ...
BrightSpring Health Services(BTSG) - 2025 Q3 - Earnings Call Transcript
2025-10-29 05:32
BrightSpring Health Services (NasdaqGS:BTSG) Q3 2025 Earnings Call October 28, 2025 04:30 PM ET Company ParticipantsA.J. Rice - Managing DirectorKieran Ryan - Equity Research AssociateJen Phipps - CFODavid Deuchler - Managing DirectorCharles Rhyee - Managing DirectorJon Rousseau - CEOLarry Solow - PartnerConference Call ParticipantsDavid Larsen - Analyst and Managing DirectorAnn Hynes - Senior Healthcare Services Equity Analyst and Managing DirectorBrian Tanquilut - Senior Analyst, Healthcare Services, and ...
BrightSpring Health Services(BTSG) - 2025 Q3 - Earnings Call Transcript
2025-10-29 05:30
BrightSpring Health Services (NasdaqGS:BTSG) Q3 2025 Earnings Call October 28, 2025 04:30 PM ET Speaker6Today, and thank you for standing by. Welcome to the BrightSpring Health Services third quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star one-one on your telephone. You will then hear an automated message advising yo ...
BrightSpring Health Services(BTSG) - 2025 Q3 - Quarterly Report
2025-10-29 04:35
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41938 BrightSpring Health Services, Inc. (Exact Name of Registrant as Specified in its Charter) | Delaware | 82-2956404 | | - ...
BrightSpring Health Services(BTSG) - 2025 Q3 - Earnings Call Presentation
2025-10-29 04:30
Third Quarter 2025 Earnings Presentation October 28, 2025 1 Forward-Looking Statements; Non-GAAP Financial Information Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, our operations and financial performance. Forward-looking statements include all statements that are not historical facts. These forward-l ...
BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
Globenewswire· 2025-10-29 04:05
LOUISVILLE, Ky., Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2025, increased Revenue guidance, and reiterated Adjusted EBITDA1 guidance. Financial Highlights(note: all figures represent continuing operations and exclude the Community Living business) Revenues of $3,334 mil ...
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
Globenewswire· 2025-10-21 09:20
LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the “Selling Stockholders”), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, of an aggregate 15,000,000 shares of common ...
BrightSpring Health Services, Inc. (BTSG) Tops Q3 Earnings and Revenue Estimates
ZACKS· 2025-10-21 06:31
核心业绩表现 - 季度每股收益为0.3美元 超出市场共识预期0.27美元 同比去年同期的0.11美元大幅增长 [1] - 本季度收益超出预期11.11% 上一季度收益为0.22美元 超出当时预期0.19美元达15.79% [1] - 季度营收达33.3亿美元 超出市场共识预期5.46% 同比去年同期的29.1亿美元增长 [2] - 公司在过去四个季度均超出每股收益和营收的共识预期 [2] 股价表现与市场比较 - 公司股价年初至今上涨约74.6% 显著超过同期标普500指数13.3%的涨幅 [3] - 股价的短期走势可持续性将主要取决于管理层在财报电话会议中的评论 [3] 未来业绩展望与预期 - 当前市场对下一季度的共识预期为每股收益0.34美元 营收33.1亿美元 [7] - 当前市场对本财年的共识预期为每股收益1.1美元 营收125亿美元 [7] - 财报发布前 公司的盈利预期修正趋势好坏参半 目前Zacks评级为第三级(持有) [6] 行业背景与同业比较 - 公司所属的医疗服务业在Zacks行业排名中位列前36% 研究显示排名前50%的行业表现优于后50%的行业超过两倍 [8] - 同业公司Alignment Healthcare预计将于10月30日公布财报 预计季度每股亏损0.07美元 同比改善50% [9] - Alignment Healthcare预计季度营收为9.8095亿美元 同比增长41.7% [10]
BrightSpring Health Services(BTSG) - 2025 Q3 - Quarterly Results
2025-10-29 04:10
收入和利润表现 - 第三季度初步收入约为33.34亿美元,同比增长28.2%[4] - 2025年第三季度总收入为33.341亿美元,相比2024年同期的26.012亿美元增长28.2%[23] - 2025年前九个月总收入为93.599亿美元,相比2024年同期的73.252亿美元增长27.8%[23] - 第三季度初步调整后税息折旧及摊销前利润约为1.6亿美元,同比增长37.2%[4] - 2025年第三季度调整后EBITDA为1.604亿美元,相比2024年同期的1.169亿美元增长37.2%[25] - 2025年前九个月调整后EBITDA为4.34亿美元,相比2024年同期的3.298亿美元增长31.6%[25] - 第三季度初步净利润约为3750万美元,去年同期为净亏损2570万美元[4] - 2025年第三季度净收入为5540万美元,相比2024年同期净亏损890万美元实现扭亏为盈[23] - 2025年前九个月净收入为1.118亿美元,相比2024年同期净亏损3590万美元实现扭亏为盈[23] - 第三季度初步毛利润约为3.92亿美元,同比增长21.3%[4] 每股收益表现 - 公司第三季度摊薄后每股收益为0.17美元,相比去年同期的-0.13美元有所改善[27] - 公司第三季度调整后每股收益为0.30美元,相比去年同期的0.03美元增长900%[27] - 公司前三季度摊薄后每股收益为0.26美元,相比去年同期的-0.37美元实现扭亏为盈[27] - 公司前三季度调整后每股收益为0.69美元,相比去年同期的0.20美元增长245%[27] 各业务部门收入表现 - 药房解决方案部门第三季度初步收入为29.67亿美元,同比增长30.9%[4][5] - 提供商服务部门第三季度初步收入为3.67亿美元,同比增长9.2%[4][5] - 2025年第三季度产品收入为29.67亿美元,相比2024年同期的22.657亿美元增长31.0%[23] - 2025年第三季度服务收入为3.671亿美元,相比2024年同期的3.355亿美元增长9.4%[23] 管理层讨论和指引 - 公司提高2025年全年收入指引至124亿至127亿美元,同比增长23.1%至26.1%[4] - 公司提高2025年全年调整后税息折旧及摊销前利润指引至6.05亿至6.15亿美元,同比增长31.5%至33.7%[4] - 社区生活业务剥离给Sevita的交易预计在2026年第一季度初完成[4] 其他财务数据 - 截至2025年9月30日,公司现金及现金等价物为1.403亿美元,相比2024年12月31日的6090万美元增长130.2%[21] - 截至2025年9月30日,公司长期债务为24.653亿美元,相比2024年12月31日的25.619亿美元减少3.8%[21] - 截至2025年9月30日,公司杠杆率约为3.31倍[4] 每股收益计算调整项 - 第三季度用于计算非GAAP每股收益的加权平均普通股为2.18亿股,高于GAAP计算所用的1.98亿股[27] - 前三季度用于计算非GAAP每股收益的加权平均普通股为2.19亿股,高于GAAP计算所用的1.91亿股[27] - 第三季度非现金股权激励费用对每股收益的调整影响为0.07美元[27] - 第三季度收购及交易相关成本对每股收益的调整影响为0.03美元[27] - 第三季度重组及其他成本对每股收益的调整影响为0.06美元[27] - 2024年第三及前三季度的所得税影响调整包含与Silver事项相关的离散税收优惠[28]
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
Globenewswire· 2025-10-21 04:15
LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced that certain of its stockholders (the “Selling Stockholders”), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, intend to offer for sale in a secondary offering an aggregate of 15,000,000 shares of common stock of BrightSprin ...